Improvement of liver enzymes was explained by the direct action of GLP-1RAs on GLP-1 receptors located on the hepatocyte that enhances weight loss, insulin sensitivity, hepatic fat oxidation, reduces denovo lipogenesis, hepatic steatosis, and alleviates oxidative stress [27–34]. This evidence concerns the gene INS and fatty liver disease.